Executives from major pharmaceutical companies outlined 2026 priorities focused on resilient API sourcing, regional finished-dose capacity, and harmonized regulatory data exchange.
Global Pharma Leaders Outline 2026 Trade and Supply Priorities
Having not yet visited Sector 10, follow these steps for a free upgrade.
